FindTrial
Sign In

Effect of Helicobacter pylori eradication on hepatogenic ulcer

Effect of Helicobacter pylori eradication on hepatogenic ulcer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061355
Enrollment
Unknown
Registered
2022-06-21
Start date
2022-06-10
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatogenic ulcer, Helicobacter pylori infection

Interventions

Triple group and single drug group:The two groups used different drugs

Sponsors

Handan First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hepatogenic ulcer infected with Helicobacter pylori.

Exclusion criteria

Exclusion criteria: 1. Non hepatogenic ulcer infected with Helicobacter pylori; 2. Patients with gastrointestinal malignancies; 3. Taking antibiotics and non steroidal anti-inflammatory drugs within the last month, and taking acid inhibitors and gastric mucosal protectors within two weeks.

Design outcomes

Primary

MeasureTime frame
Helicobacter pylori eradication rate;—

Countries

China

Contacts

Public ContactQiao Guan'en

Handan First Hospital

627559246@qq.com+8613832057097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026